BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 34737738)

  • 41. N-α-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis.
    Willis VC; Gizinski AM; Banda NK; Causey CP; Knuckley B; Cordova KN; Luo Y; Levitt B; Glogowska M; Chandra P; Kulik L; Robinson WH; Arend WP; Thompson PR; Holers VM
    J Immunol; 2011 Apr; 186(7):4396-404. PubMed ID: 21346230
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epitope-Based Chicken-Derived Novel Anti-PAD2 Monoclonal Antibodies Inhibit Citrullination.
    Aosasa M; Hossain MS; Sakata T; Koga K; Shigemitsu T; Shoya Y; Yamaguchi M; Saito K; Kim M
    J Immunol Res; 2021; 2021():6659960. PubMed ID: 33937418
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myocardial citrullination in rheumatoid arthritis: a correlative histopathologic study.
    Giles JT; Fert-Bober J; Park JK; Bingham CO; Andrade F; Fox-Talbot K; Pappas D; Rosen A; van Eyk J; Bathon JM; Halushka MK
    Arthritis Res Ther; 2012 Feb; 14(1):R39. PubMed ID: 22364592
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Screening of natural inhibitors against peptidyl arginine deiminase 4 from herbal extracts by a high-performance liquid chromatography ultraviolet-visible based method.
    Zhao J; Li Y; Gao C; Zhao Z; Zhang S; Dong J; Zuo H; Chen X; Xie B; Guo Z; Wang Y; Li H; Bian Y
    J Chromatogr A; 2024 Feb; 1716():464643. PubMed ID: 38232639
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis.
    Darrah E; Rosen A; Giles JT; Andrade F
    Ann Rheum Dis; 2012 Jan; 71(1):92-8. PubMed ID: 21859690
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of PAD2 Improves Survival in a Mouse Model of Lethal LPS-Induced Endotoxic Shock.
    Wu Z; Deng Q; Pan B; Alam HB; Tian Y; Bhatti UF; Liu B; Mondal S; Thompson PR; Li Y
    Inflammation; 2020 Aug; 43(4):1436-1445. PubMed ID: 32239392
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reciprocal regulation of Th2 and Th17 cells by PAD2-mediated citrullination.
    Sun B; Chang HH; Salinger A; Tomita B; Bawadekar M; Holmes CL; Shelef MA; Weerapana E; Thompson PR; Ho IC
    JCI Insight; 2019 Nov; 4(22):. PubMed ID: 31723060
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel method to quantify peptidylarginine deiminase activity shows distinct citrullination patterns in rheumatoid and juvenile idiopathic arthritis.
    Yu K; Dillemans L; Gouwy M; Bessa H; Metzemaekers M; Martens E; Matthys P; Bossuyt X; Verschueren P; Wouters C; De Somer L; Proost P
    Front Immunol; 2023; 14():1111465. PubMed ID: 36793709
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Peptidyl arginine deiminase inhibition suppresses arthritis via decreased protein citrullination in joints and serum with the downregulation of interleukin-6.
    Kawaguchi H; Matsumoto I; Osada A; Kurata I; Ebe H; Tanaka Y; Inoue A; Umeda N; Kondo Y; Tsuboi H; Ishigami A; Sumida T
    Mod Rheumatol; 2019 Nov; 29(6):964-969. PubMed ID: 30285515
    [No Abstract]   [Full Text] [Related]  

  • 50. Expanding the citrullinome of synovial fibrinogen from rheumatoid arthritis patients.
    Sharma M; Damgaard D; Senolt L; Svensson B; Bay-Jensen AC; Nielsen CH; Hägglund P
    J Proteomics; 2019 Sep; 208():103484. PubMed ID: 31408709
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy.
    Choudhury RH; Symonds P; Paston SJ; Daniels I; Cook KW; Gijon M; Metheringham RL; Brentville VA; Durrant LG
    J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35140112
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Citrullination-Resistant LL-37 Is a Potent Antimicrobial Agent in the Inflammatory Environment High in Arginine Deiminase Activity.
    Bryzek D; Golda A; Budziaszek J; Kowalczyk D; Wong A; Bielecka E; Shakamuri P; Svoboda P; Pohl J; Potempa J; Koziel J
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Small molecule activates citrullination through targeting PAD2.
    Zhang X; Shen M; Zhu H; Zhang J; Yang M; Su K; Zhang Y; Fu W; Ke X; Qu Y
    Philos Trans R Soc Lond B Biol Sci; 2023 Nov; 378(1890):20220248. PubMed ID: 37778388
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Potential role for peptidylarginine deiminase 2 (PAD2) in citrullination of canine mammary epithelial cell histones.
    Cherrington BD; Morency E; Struble AM; Coonrod SA; Wakshlag JJ
    PLoS One; 2010 Jul; 5(7):e11768. PubMed ID: 20668670
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Autodeimination of protein arginine deiminase 4 alters protein-protein interactions but not activity.
    Slack JL; Jones LE; Bhatia MM; Thompson PR
    Biochemistry; 2011 May; 50(19):3997-4010. PubMed ID: 21466234
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Insight into Neutrophil Extracellular Traps through Systematic Evaluation of Citrullination and Peptidylarginine Deiminases.
    Holmes CL; Shim D; Kernien J; Johnson CJ; Nett JE; Shelef MA
    J Immunol Res; 2019; 2019():2160192. PubMed ID: 30993117
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of a Selective Inhibitor of Protein Arginine Deiminase 2.
    Muth A; Subramanian V; Beaumont E; Nagar M; Kerry P; McEwan P; Srinath H; Clancy K; Parelkar S; Thompson PR
    J Med Chem; 2017 Apr; 60(7):3198-3211. PubMed ID: 28328217
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development and use of clickable activity based protein profiling agents for protein arginine deiminase 4.
    Slack JL; Causey CP; Luo Y; Thompson PR
    ACS Chem Biol; 2011 May; 6(5):466-76. PubMed ID: 21265574
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peptidylarginine deiminases 2 and 4 modulate innate and adaptive immune responses in TLR-7-dependent lupus.
    Liu Y; Lightfoot YL; Seto N; Carmona-Rivera C; Moore E; Goel R; O'Neil L; Mistry P; Hoffmann V; Mondal S; Premnath PN; Gribbons K; Dell'Orso S; Jiang K; Thompson PR; Sun HW; Coonrod SA; Kaplan MJ
    JCI Insight; 2018 Dec; 3(23):. PubMed ID: 30518690
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peptidylarginine deiminase-4: Medico-formulative strategy towards management of rheumatoid arthritis.
    Thirugnanasambandham I; Radhakrishnan A; Kuppusamy G; Kumar Singh S; Dua K
    Biochem Pharmacol; 2022 Jun; 200():115040. PubMed ID: 35436466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.